Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000084324 | SCV000576929 | likely pathogenic | not provided | 2017-04-14 | criteria provided, single submitter | clinical testing | The S169P variant in the PSEN1 gene has been reported previously in the heterozygous state in two siblings with early onset Alzheimer disease (Ezquerra et al., 1999). The S169P variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The S169P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In addition, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (A164V, W165G, W165C, L166V, L166P, L166R, L166H, I168T, S170F, L171P, L173W, L173F, L174M, L174R) and at the same residue (S169L) have been reported in the Human Gene Mutation Database in association with Alzheimer disease (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret S169P as a likely pathogenic variant. |
VIB Department of Molecular Genetics, |
RCV000084324 | SCV000116460 | not provided | not provided | no assertion provided | not provided |